science1 distinct publisher
An FDA panel wants unapproved peptides sold by prescription. That is deregulation, not wellness.
An advisory panel voted to route peptides marketed for sleep, wound healing and cognition through compounding pharmacies, which face less oversight and may dispense unapproved drugs.
Publishers:livescience.com
Reality
- Evidence60
- Adoption45
- Hype gap+35
- Incentives70
- Confidence50